Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $10.8 million.

  • InspireMD's Total Current Liabilities rose 4887.82% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 4887.82%. This contributed to the annual value of $7.7 million for FY2024, which is 2754.15% up from last year.
  • Per InspireMD's latest filing, its Total Current Liabilities stood at $10.8 million for Q3 2025, which was up 4887.82% from $9.1 million recorded in Q2 2025.
  • InspireMD's 5-year Total Current Liabilities high stood at $10.8 million for Q3 2025, and its period low was $2.9 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $5.6 million, with a median of $4.8 million in 2023.
  • As far as peak fluctuations go, InspireMD's Total Current Liabilities skyrocketed by 248.3% in 2023, and later skyrocketed by 5490.41% in 2024.
  • Over the past 5 years, InspireMD's Total Current Liabilities (Quarter) stood at $4.3 million in 2021, then increased by 16.63% to $5.1 million in 2022, then grew by 18.74% to $6.0 million in 2023, then rose by 27.54% to $7.7 million in 2024, then soared by 40.87% to $10.8 million in 2025.
  • Its Total Current Liabilities stands at $10.8 million for Q3 2025, versus $9.1 million for Q2 2025 and $7.4 million for Q1 2025.